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Abstract 
Background: General anesthesia draws attention to the most commonly used modalities 
for post cesarean delivery pain relief in systemic administration of opioids, while the 
administration of small dose of intrathecal opioid during spinal anesthesia can be a 
possible alternative. The aim of this study was to evaluate the effects of buprenorphine on 
cesarean section prescribed intrathecally. 
Methods: This double blind randomized clinical trial study was conducted in patients for 
cesarean section under spinal anesthesia. The patients were randomly divided into case and 
control groups. Case group (208 patients) received 65-70 mg of 5% lidocaine plus 0.2 ml 
of buprenorphine while the same amount of 5% lidocaine diluted with 0.2 ml of normal 
saline was given to 234 cases in the control group. Hemodynamic changes and neonatal 
APGAR scores (Appearance, Pulse, Grimace, Activity, Respiration) were recorded. Pain 
score was recorded according to the visual analog scale. This study was registered in the 
Iranian Registry of clinical Trials; IRCT2013022112552N1. 
Results: The mean age of case and control groups was 24.4±5.38 and 26.84±5.42 years, 
respectively. Systolic blood pressure was not significantly different until the 45th minute 
but diastolic blood pressure showed a significant difference at the 15th and the 60th 
minutes (P<0.001). Heart rate changes were significantly different between cases and 
controls at the initial 5th, 15th and after 60th minutes (P<0.001). Pain-free period was 
significantly different between two groups (1.25 h versus 18.73 h) (P<0.001). 
Conclusion: The results show that prescription of intratechal buprenorphine prolongs the 
duration of analgesia without any significant considerable side effects. 
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The increasing cesarean section rate is a global issue in the developed and 
developing countries (1). It has shown a rapid and significant rise during the past 30 years. 
The statistics from the Ministry of Health and Medical Education of Iran reported that 
about 40.7% of all deliveries are cesarean section all throughout (2). Because of the 
increasing risks associated with anesthesia in pregnant women, there is a greater tendency 
toward neuroaxial anesthesia in cesarean section (3). Spinal anesthesia is the method of 
choice in cesarean section (4). Post cesarean delivery pain relief is important. Good pain 
relief will improve mobility and can reduce the risk of thromboembolic disease, which 
increases during pregnancy. It is necessary that pain relief be safe and effective not 
interfering with the mother’s ability to move around and care for her infant, without 
leading to any adverse neonatal effects. The most commonly used modalities are systemic 
administration of opioids, either by intravenous or intramuscular injection, and 
intratheraceal injection of opioid as part of a regional anesthetic for cesarean delivery (5). 
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It is proposed that by adding a small dose of opioid to 
local anesthetic solution, the duration of analgesia can be 
significantly prolonged without increasing side effects. 
Intratecal narcotics enhance the sensory blockade of local 
anesthetics without affecting the sympathetic activity (6). In 
this method, the annoying complaints like numbness and 
immobility decrease after recovery. Adding opioid to local 
anesthetics reduces pain severity during and after surgery 
and reduces the necessary doses of anesthetic (7).  
Buprenorphine is a long-acting, lipid soluble, mixed 
agonist-antagonist opioid that has been used in clinical 
practice since 1979. Buprenorphine is a thebaine derivative 
with a partial agonist activity at the μ-opioid receptor. 
Buprenorphine is administered via intravenous, 
intramuscular, sublingual, and intrathecal routs. It has been 
used for the treatment of acute/chronic pain and also as a 
supplement drug in anesthesia. Since buprenorphine 
dissociates slowly from μ-opioid receptor, it has long 
duration of action and less addiction potential (8). Like other 
agonist-antagonist opioids, buprenorphine cannot be used as 
a single anesthetic. Lidocaine is the most common used local 
anesthetic. Lidocaine has an extensive use in spinal 
anesthesia and with widespread popularity. It is a known 
local anesthetic for spinal anesthesia among obstetric 
patients (9). 
The aim of this study was to evaluate the efficacy and the 
adverse effects of intrathecal buprenorphine in cesarean 
section while there is a paucity of published literature 
assessing buprenorphine when prescribed intrathecally. 
 
 
Methods 
From June 2010 to December 2012 all patient candidates 
for elective cesarean section and in ASA class I (American 
Society of Anesthesiology) aged 17-41 years were included 
for this study. The patients with local infection at the site of 
lumbar puncture, any contraindication for lumbar puncture, 
disorders of the spine, alcoholic patients or those with 
history of drug abuse, collagen vascular disease, NSAIDs or 
corticosteroid use, psychotic problems, bleeding disorders, 
space occupying lesions of the brain, fetal or maternal 
contraindications for spinal anesthesia, severe fetus distress, 
blood pressure more than 140/90 mmHg, gestational 
diabetes, cardiopulmonary diseases and a height of less than 
150 cm were excluded. The main variable in this study was 
pain and the sample size was calculated on the basis of mean 
differences of pain perception (VAS score) in other studies. 
Based on clinical experience and review of literature, an 
educated guess was made that a difference in pain score 
about 1-2 according to VAS scale between two groups 
would be statistically significant. Using the data and 
assuming a study with 90% power and probability of making 
a type I error of 5%, a sample size of four hundred patients 
was required to obtain the statistical significance. So, 
assuming the equal distribution of patients in both groups, 
four hundred and forty-two healthy full term pregnant 
women incorporated in the study were randomly divided into 
two groups using a computer-generated randomization table 
(simple random sampling) according to their profile 
number:case group (lidocaine and buprenorphine) and 
control group (lidocaine).  
The explanation regarding the procedure and study, 
education regarding VAS score, and necessary written 
informed consent was done during the preoperative checkup 
at visit.  
Standard ASA fasting guidelines were followed by all 
patients upon arrival at the operation theatre, intravenous 
access was established with an 18G intravenous cannula in a 
large vein of forearm, and ringer or normal saline (0.9%) 
was infused before anesthesia (300-500 ml) and vital signs 
(pulse oximetry, blood pressure and heart rate) were 
measured and recorded. Then the patients were positioned 
into a sitting position with the help of a nurse and pulse-
oximeter was connected. Dural puncture was done after prep 
in L3-L4 or L4-L5 levels and after assuring about the CSF, 
anesthetic drug was infused during 10-15 seconds into the 
subarachnoid space. Then the patients were positioned back 
to the supine position and ECG monitoring, non-invasive 
automatic blood pressure evaluation and pulse-oximetry 
were performed. Spinal anesthesia was performed for all 
cases. To ensure blinding, the randomly allocated coded 
syringes of drugs were prepared by a clinical anesthesia 
resident but did not perform subarachnoid block or record 
the outcome intraoperative and postoperative period. The 
investigator and the attending anesthesiologist performing 
the study were blinded to the content of the drugs contained 
in each syringe. 
In the case group, 65-70 mg (1.3 to 1.4 ml) of 5% 
lidocaine plus 0.2 ml of buprenorphine was infused and in 
the control group, 65-70 mg (1.3-1.4 ml) of 5% lidocaine 
plus 0.2 ml of 0.9% normal saline was infused. 
Hemodynamic factors like blood pressure and heart rate 
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were recorded before and at 1, 3, 5, 15, 30, 45, 60 and 75 
minutes after spinal anesthesia. Severe decrease in 
hemodynamic elements was treated appropriately. Surgery 
was started about 4-5 minutes after induction. 1500-1800 ml 
isotonic serum was given intravenously to patients during the 
surgery. Neonatal APGAR (Appearance, Pulse, Grimace, 
Activity and Respiration) score was recorded at the 1st and 
the 5
th
 minutes after delivery.  
Oxygen (3 L/min) was administered throughout the 
procedure via nasal cannula. Intraoperative fluid 
management was done in relation to body weight of the 
patient, vital signs, and intraoperative losses. At the end of 
the surgery, the patients were transferred to the recovery 
room and monitored by pulseoximetery and NIBP (non 
invasive blood pressure). Postoperatively, all patients in the 
study were visited daily and were asked for the presence of a 
headache and any accompanying symptoms. The pain onset 
was recorded according to the visual analog scale (VAS) 
with facial expression (10, 11). Based on this score, no, mild, 
moderate, severe and worst imaginable pains were measured.  
If there was a moderate to severe pain, 0.5 mg/kg IV 
pethidine was administrated. In the ward, if there was a 
moderate pain diclofenac suppository (100 mg) was given, in 
case of, severe pain or no response to the suppository, 
Intramuscular pethidine was prescribed. All patients were 
under observation with regard to probable buprenorphine 
side effects. This study was registered in the Iranian Registry 
of Clinical Trials of the Ministry of Health (a branch of 
World Health Organization) by IRCT2013022112552N1. 
Data were collected and analyzed using SPSS Version 16. 
For the categorical variables, chi-square test or Fisher’s exact 
test was used (VAS score, APGAR). The mean of 
continuous data were compared between the two groups 
using Mann-Whitney and ANOVA tests (age, hemodynamic 
parameters). We also used t-test for comparing the data 
between two groups as it was necessary (pain free period, 
analgesic consumption). The significance level was defined 
as a p-value less than 0.05. 
 
 
Results 
Two hundred eight cases (case group) and 243 subjects 
(the control group) were selected. The mean age of the case 
group was 24.4±5.38 and in the control group was 
26.84±5.42 years (P=0.389). Systolic blood pressure was not 
significantly different until the 45th minute but it turned to 
be significant later on (P<0.001). Diastolic blood pressure 
showed a significant difference at the 15th minute and after 
the 60th minute. Heart rate changes were significantly 
different between cases and controls at 5, 15 and after 60th 
minutes (P<0.001) (table 1). Hemodynamic changes are 
shown in Figures 1 and 2. Pain-free period was significantly 
different between the two groups (P<0.001) (1.25 hours in 
controls and 18.73 hours in cases). The data showed that all 
208 patients in the control group received IV analgesia 
during 24 hours after surgery. Sixty-one patients received 
one dose of pethidine and 139 received twice. In contrast, 
100 patients in the case group received no analgesia, 115 
only one prescription of diclofenac suppository (100 mg) and 
18 cases, one dose of IV pethidine. 
Nausea vomiting and itching were not significantly 
different between the two groups. APGAR score was not 
significantly different between the two groups (P=0.154). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure1. Systolic blood pressure changes in the two 
studied groups 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Diastolic blood pressure changes in the two 
studied groups. 
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Table 1. Comparing mean±SD of heart rate between 
cases and controls 
 
P-value Mean±SD Group 
Minutes after spinal 
anesthesia 
control Case 
0.110 113±23 109±28 0 
0.145 124±19 127±23 1
 
 
0.176 118±26 121±19 3  
0.005 136±19 131±17 5  
0.001 105±27 113±24 15  
0.010 96±23 101±16 30  
0.065 94±19 98±25 45  
0.000 97±25 84±17 60  
0.000 108±23 89±20 75 
 
 
Discussion 
In this clinical trial study, the efficacy and complications 
of intrathecal buprenorphine in elective cesarean section 
were evaluated. It has been shown that the mean of pain-free 
period in the study group (intrathecal lidocaine plus 
bupernorphine) was 17.65 hours more than the control group 
(plain intrathecal lidocaine), in which most of these patients 
did not have any pain during the first 24 hours or the pain 
was resolved by diclofenac suppository. Other studies 
showed that adding opioids to local analgesic is an 
acceptable method to do spinal anesthesia. Prolonged of 
pain-free period after cesarean section is one of the 
advantages of spinal anesthesia (7, 12). The present results 
showed that the supplementation of spinal lidocaine with 
buprenorphine significantly prolonged the sensory block and 
postoperative analgesia compared with plain intrathecal 
lidocaine without any effects on the onset time of sensory 
block in cesarean section. The safety of intrathecal 
buprenorphine in caesarean section and its efficacy for 
postoperative analgesia has been shown in an investigation, 
too (13). Khan et al. compared analgesia after spinal 
anesthesia between fentanyle plus bupivacaine and 
bupivacaine plus buprenorphine and bupivacaine alone. They 
concluded that adding buprenorphine to bupivacaine could 
induce longer pain-free periods (6). 
Candidio et al. reported that adding buprenorphine to a 
local analgesic could increase the pain- free period three-
times in the method of brachial plexus block (14). In a study 
in Iran showed that analgesia with lidocaine plus 
buprenorphine was so much longer than lidocaine alone and 
no hemodynamic changes were seen in both groups (15). 
Johnson et al. evaluated the different patients under surgery 
(laparatomy, gynecology and cardiac surgery) with regard to 
the adverse effects of buprenorphine. They observed that 
nausea vomiting and lightheadness were much prevalent 
with buprenorphine, but the other side effects like decrease 
in respiratory rate and sleepiness were not different 
compared to other opioids.  
Higher doses of intrathecal bupernorphine (0.3-0.9 mg) 
were associated with low side effects and few more 
advantages like duration of effect or quality of analgesia. 
Intrathecal bupernorphine could induce 12-24 hours 
analgesia. As to compare buprenorphine (0.6 mg) with 
methadone (20 mg) during hysterectomy, the patients who 
received buprenorphine requested for less analgesia and had 
longer pain-free period (16). 
In the present study, changes in heart rate and blood 
pressure were significantly different between cases and 
controls after the 60
th
 minute and more remarkable in 
controls which showed the back pain in those who received 
lidocaine alone. 
It has been shown that spinal anesthesia for cesarean 
section is associated with hypotension in mother. Turhanoglu 
et al. designed a study to evaluate the advantage of 
intrathecal administration of low dose bupivacaine in 
cesarean section. They showed that adding bupivacaine (4 
mg) to fentanyl (25 mg) did not prevent hypotension but 
reduced its severity and the dosage needed for treatment by 
ephedrine (17). It is also reported that the risk of hypotension 
in mother during cesarean section with local anesthesia can 
be diminished by the administration of ephedrine or 
phenylephedrine IV or rise in blood volume with crystalloid 
or colloids (18). 
In the present study, no significant differences were seen 
between two groups regarding apnea, nausea vomiting and 
itching. Epidural buprenorphine was used in a study on those 
with multiple rib fractures and more analgesia and early 
recovery was reported without significant effects on 
cardiovascular systems or inducing nausea vomiting and 
itching (19). 
This investigation showed that using intrethecal 
buprenorphine in cesarean section prolongs the duration of 
analgesia without any significant changes in hemodynamic 
status, respiratory problems, side effects like nausea, 
vomiting and itching. 
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